Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/37085
Year of Publication: 
2010
Series/Report no.: 
Jena Economic Research Papers No. 2010,045
Publisher: 
Friedrich Schiller University Jena and Max Planck Institute of Economics, Jena
Abstract: 
This paper investigates the determinants of success in the development of new drugs. In specific, it explores the factors of success in drug development programs at different stages of innovation process. We use economies of scale, scope, R&D competition and technological spillovers as explanatory variables and test whether the effect of these variables on the success of a project differs in relation to the discovery and development stages of innovation, respectively. Our main finding is that spillovers, including spillovers from collaboration, are important in explaining the success of projects during the discovery stage of innovation, while in the later development stage, the effects of competition outweigh any benefits from spillovers.
Subjects: 
economies of scale and scope
spillovers
competition
R&D
innovation process
JEL: 
O32
L25
L65
Document Type: 
Working Paper

Files in This Item:
File
Size
761.44 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.